A multicenter open-label phase II trial to evaluate nivolumab and ipilimumab for 2nd line therapy in elderly patients with advanced esophageal squamous cell cancer (RAMONA)

Overview of attention for article published in BMC Cancer, March 2019

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 27 Dimensions

Readers on

mendeley: 82 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 1,254 followers.

A multicenter open-label phase II trial to evaluate nivolumab and ipilimumab for 2nd line therapy in elderly patients with advanced esophageal squamous cell cancer (RAMONA). https://t.co/iFBwohj7A0

02 Jul 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.